Biogen Idec's Plegridy gets CHMP backing

EMA's CHMP backed approval of Plegridy peginterferon beta-1a ( BIIB017) from Biogen Idec Inc. (NASDAQ:BIIB) to treat relapsing-remitting multiple sclerosis (RRMS). A BLA for the pegylated interferon (...